2-[[2-(2-bromo-4-chlorophenoxy)acetyl]-[(4-methoxyphenyl)methyl]amino]-N-cyclohexylpropanamide
C25H30BrClN2O4 — CID 132624861
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[2-(2-bromo-4-chlorophenoxy)acetyl]-[(4-methoxyphenyl)methyl]amino]-N-cyclohexylpropanamide
2-[[2-(2-bromo-4-chlorophenoxy)acetyl]-[(4-methoxyphenyl)methyl]amino]-N-cyclohexylpropanamide (PubChem CID 132624861) has the molecular formula C25H30BrClN2O4 and a molecular weight of 537.88 g/mol. Its IUPAC name is 2-[[2-(2-bromo-4-chlorophenoxy)acetyl]-[(4-methoxyphenyl)methyl]amino]-N-cyclohexylpropanamide.
Molecular Properties
| Compound Name | 2-[[2-(2-bromo-4-chlorophenoxy)acetyl]-[(4-methoxyphenyl)methyl]amino]-N-cyclohexylpropanamide |
|---|---|
| PubChem CID | 132624861 |
| Molecular Formula | C25H30BrClN2O4 |
| Molecular Weight | 537.88 g/mol |
| Exact Mass | 536.11 |
| IUPAC Name | 2-[[2-(2-bromo-4-chlorophenoxy)acetyl]-[(4-methoxyphenyl)methyl]amino]-N-cyclohexylpropanamide |
| SMILES | COc1ccc(CN(C(=O)COc2ccc(Cl)cc2Br)C(C)C(=O)NC2CCCCC2)cc1 |
| InChI | InChI=1S/C25H30BrClN2O4/c1-17(25(31)28-20-6-4-3-5-7-20)29(15-18-8-11-21(32-2)12-9-18)24(30)16-33-23-13-10-19(27)14-22(23)26/h8-14,17,20H,3-7,15-16H2,1-2H3,(H,28,31) |
| InChIKey | DWABRDCQSNULQH-UHFFFAOYSA-N |
| XLogP | 5.36 |
| TPSA | 67.87 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 537.88 |
| LogP ≤ 5 | 5.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 132624861 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.